456 related articles for article (PubMed ID: 18550382)
21. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
22. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.
Park CS; Kim YJ; Lee JR; Lim HG; Chang JE; Jeong S; Kwon N
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):391-399. PubMed ID: 28505294
[TBL] [Abstract][Full Text] [Related]
23. Combined anticalcification treatment of bovine pericardium with decellularization and hyaluronic acid derivative.
Zhu D; Jin L; Wang X; Xu L; Liu T
Biomed Mater Eng; 2014; 24(1):741-9. PubMed ID: 24211959
[TBL] [Abstract][Full Text] [Related]
24. Biocompatibility of aldehyde-fixed bovine pericardium. An in vitro and in vivo approach toward improvement of bioprosthetic heart valves.
Grimm M; Eybl E; Grabenwöger M; Griesmacher A; Losert U; Böck P; Müller MM; Wolner E
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):195-201. PubMed ID: 1678026
[TBL] [Abstract][Full Text] [Related]
25. Determinants of calcium uptake of bovine pericardium for heart valve replacement: results of in vitro studies.
Dahm M; Dohmen G; Prüfer D; Krummenauer F; Hafner G; Oelert H
J Heart Valve Dis; 1998 Mar; 7(2):170-3. PubMed ID: 9587857
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of in vivo models for studying calcification behavior of commercially available bovine pericardium.
Quintero LJ; Lohre JM; Hernandez N; Meyer SC; McCarthy TJ; Lin DS; Shen SH
J Heart Valve Dis; 1998 May; 7(3):262-7. PubMed ID: 9651837
[TBL] [Abstract][Full Text] [Related]
27. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue.
Zilla P; Weissenstein C; Bracher M; Zhang Y; Koen W; Human P; von Oppell U
J Heart Valve Dis; 1997 Sep; 6(5):502-9. PubMed ID: 9330172
[TBL] [Abstract][Full Text] [Related]
28. Donkey pericardium as an alternative bioprosthetic heart valve material.
Chen S; Xu L; Liu Y; Li Q; Wang D; Wang X; Liu T
Artif Organs; 2013 Mar; 37(3):248-55. PubMed ID: 23145868
[TBL] [Abstract][Full Text] [Related]
29. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability?
Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860
[TBL] [Abstract][Full Text] [Related]
30. Kangaroo vs. porcine aortic valves: calcification potential after glutaraldehyde fixation.
Narine K; Chéry CC; Goetghebeur E; Forsyth R; Claeys E; Cornelissen M; Moens L; Van Nooten G
Eur Surg Res; 2005; 37(3):137-43. PubMed ID: 16088178
[TBL] [Abstract][Full Text] [Related]
31. Effect of SDS-based decelullarization in the prevention of calcification in glutaraldehyde-preserved bovine pericardium: study in rats.
Collatusso C; Roderjan JG; Vieira ED; Costa FD; Noronha Ld; Fornazari Dde F
Rev Bras Cir Cardiovasc; 2012; 27(1):88-96. PubMed ID: 22729305
[TBL] [Abstract][Full Text] [Related]
32. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering.
Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH
Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635
[TBL] [Abstract][Full Text] [Related]
33. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.
Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):99-105. PubMed ID: 11805957
[TBL] [Abstract][Full Text] [Related]
34. Acidic glycoproteins accumulate in calcified areas of bioprosthetic tissue.
Grabenwöger M; Böck P; Fitzal F; Schmidberger A; Grimm M; Laufer G; Bergmeister H; Wolner E
J Heart Valve Dis; 1998 Mar; 7(2):229-34. PubMed ID: 9587867
[TBL] [Abstract][Full Text] [Related]
35. Two stage EDTA anti-calcification method for bioprosthetic heart valve materials.
Sucu N; Karaca K; Yilmaz N; Cömelekoglu U; Aytacoglu BN; Tamer L; Ozeren M; Dondas HA; Oğuz Y; Ogenler O; Dikmengil M
Med Sci Monit; 2006 Jun; 12(6):MT33-8. PubMed ID: 16733494
[TBL] [Abstract][Full Text] [Related]
36. Effects of glutaraldehyde concentration, pretreatment time, and type of tissue (porcine versus bovine) on postimplantation calcification.
Sinha P; Zurakowski D; Kumar TK; He D; Rossi C; Jonas RA
J Thorac Cardiovasc Surg; 2012 Jan; 143(1):224-7. PubMed ID: 22047684
[TBL] [Abstract][Full Text] [Related]
37. Fixation of vascular grafts with increased glutaraldehyde concentration enhances mechanical properties without increasing calcification.
Sánchez DM; Gaitán DM; León AF; Mugnier J; Briceño JC
ASAIO J; 2007; 53(3):257-62. PubMed ID: 17515713
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of different anticalcification treatments for stentless aortic bioprostheses.
Walther T; Falk V; Diegeler A; Rauch T; Weigl C; Gummert J; Autschbach R; Mohr FW
Thorac Cardiovasc Surg; 1999 Feb; 47(1):23-5. PubMed ID: 10218616
[TBL] [Abstract][Full Text] [Related]
39. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.
Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E
Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007
[TBL] [Abstract][Full Text] [Related]
40. Dynamic in vitro calcification of bioprosthetic porcine valves: evidence of apatite crystallization.
Pettenazzo E; Deiwick M; Thiene G; Molin G; Glasmacher B; Martignago F; Bottio T; Reul H; Valente M
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):500-9. PubMed ID: 11241085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
